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Mass spectrometry imaging of 
biomarker lipids for phagocytosis 
and signalling during focal cerebral 
ischaemia
Mette M. B. Nielsen1, Kate L. Lambertsen2, Bettina H. Clausen2, Morten Meyer2, 
Dhaka R. Bhandari3, Søren T. Larsen4, Steen S. Poulsen5, Bernhard Spengler3, 
Christian Janfelt6 & Harald S. Hansen1
Focal cerebral ischaemia has an initial phase of inflammation and tissue injury followed by a later 
phase of resolution and repair. Mass spectrometry imaging (desorption electrospray ionization and 
matrix assisted laser desorption ionization) was applied on brain sections from mice 2 h, 24 h, 5d, 7d, 
and 20d after permanent focal cerebral ischaemia. Within 24 h, N-acyl-phosphatidylethanolamines, 
lysophosphatidylcholine, and ceramide accumulated, while sphingomyelin disappeared. At the 
later resolution stages, bis(monoacylglycero)phosphate (BMP(22:6/22:6)), 2-arachidonoyl-glycerol, 
ceramide-phosphate, sphingosine-1-phosphate, lysophosphatidylserine, and cholesteryl ester 
appeared. At day 5 to 7, dihydroxy derivates of docosahexaenoic and docosapentaenoic acid, 
some of which may be pro-resolving mediators, e.g. resolvins, were found in the injured area, and 
BMP(22:6/22:6) co-localized with the macrophage biomarker CD11b, and probably with cholesteryl 
ester. Mass spectrometry imaging can visualize spatiotemporal changes in the lipidome during the 
progression and resolution of focal cerebral inflammation and suggests that BMP(22:6/22:6) and N-acyl-
phosphatidylethanolamines can be used as biomarkers for phagocytizing macrophages/microglia cells 
and dead neurones, respectively.
Mass spectrometry imaging (MSI) has increasingly been used to visualize abundance of various molecular species 
of phospholipids in the tissues1,2, including neuronal tissues3,4. This technique holds a great potential to visualize 
and identify complicated biological processes and cell movements in time and space during localized changes 
in a tissue, e.g. during inflammation initiation and resolution following focal cerebral ischaemia. Especially, we 
have hypothesized that the increased presence of the uncommon phospholipids, bis(monoacylglycero)phosphate 
(BMP)5 and N-acyl-phosphatidylethanolamine (NAPE)6, in brain tissue could be used as biomarkers of phago-
cytizing macrophages/microglia cells and dead/dying neurones, respectively. Furthermore, it should be possible 
to visualize the time course of generation of a number of lipid mediators promoting and resolving inflammation 
in mouse brains exposed to permanent middle cerebral artery occlusion (pMCAO). Focal cerebral ischaemia 
is characterized with an early ischaemic core surrounded by a penumbra through which the infarct is growing 
within the first couple of hours after the ischaemic insult7,8. The first 24 h or more includes an early inflammatory 
phase involving neutrophil infiltration and release of cytokines and eicosanoids, but after several days it is fol-
lowed by resolution involving phagocytosis of apoptotic cells and cell debris by macrophages/microglia cells and 
regeneration9,10. However, MSI of the progression of these processes with focus on lipid biomarkers and abun-
dance of signalling lipid mediators have not been investigated before.
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MSI has already illustrated that during the initial ischaemic phase lysophosphatidylcholine (LysoPC) will 
accumulate in the ischaemic area11–14, as well as a cessation of Na+/K+-ATPase activity during cell death can 
be visualized as a decrease in the abundance of the potassium adduct of intracellular phosphatidylcholine (e.g. 
PC(34:1)) and an increase in the abundance of the sodium adduct of the same PC species13,14. Furthermore, 
ceramides (Cer), N-acyl-ethanolamines (NAE), free fatty acids, prostaglandins, and 2-arachidonoylglycerol have 
been seen by MSI to accumulate in the ischaemic area during the early phase of ischaemia. At the same time 
sphingomyelin (SM) decreases in abundance12–16. We have now searched for the spatiotemporal abundance of 
other PC species, especially docosahexaenoic-containing PC (e.g. PC(18:0/22:6)) and arachidonic-containing 
PC (e.g. PC(18:0/20:4)), since they have been suggested to be biomarkers for neurones and invasive immune 
cells, respectively12. Since we observed a change in the Na+/K+-adduct abundance of several PC species, we also 
visualized the abundance of the Na+/K+-adducts of sphingomyelin (SM(d18:1/18:0)), because it is generally con-
sidered to be localized mainly on the outer leaflet of cells, thereby facing a high sodium concentration17. We 
have previously reported that NAPE accumulates during brain ischaemia in the injured area13,18–20, and studies 
of primary cerebral cell cultures suggest that NAPE particularly is generated in dying/dead neurones and not in 
astrocytes21,22. Thus, we have used NAPE as a spatiotemporal biomarker for the abundance of dead neurones in 
the ischaemic brain. BMP is a low abundant phospholipid in all cells being confined to the endosomal/lysoso-
mal vesicles5,23, but it is especially abundant in macrophages/microglia cells24, where it is primarily localized to 
phagosomes25. We have investigated whether BMP can be used as a biomarker phospholipid for macrophages/
microglia cells performing phagocytosis during the repair phase of focal cerebral ischaemia. In this context, we 
have also searched for the visualization of lysophosphatidylserines (LysoPSs), since they appear to be signalling 
lipids that regulate immunological and neurological processes via membrane receptors, including stimulation of 
phagocytosis by macrophages26,27. Furthermore, we have also searched for a number of other signalling lipids, 
including sphingolipid metabolites, monoacylglycerols (MAGs), and dihydroxy-derivates of docosahexaenoic 
acid (DHA) and docosapentaenoic acid (DPA). Of the sphingolipid derivates, both sphingosine-1-phosphate 
(S1P) as an intercellular messenger28 and ceramide-1-phosphate (CerP), whether extracellular or intracellu-
lar29, have been implicated in regulation of neuronal damage30,31. The endocannabinoid, 2-arachidonoylglycerol 
(2-AG), is an important neuromodulator in the brain in both normal physiology32 as well as during brain injury33, 
but also as a precursor for eicosanoids during neuroinflammation34. The tissue level of 2-AG had been reported to 
be increased at 4 h or at 24 h after permanent damage to the brain (trauma or ischaemia) in mice13,18,35, but it is not 
known how levels of 2-AG are in the late resolving phase. Within recent years, di- and tri-hydroxylated derivates 
of DHA and DPA, some of which are called protectins, resolvins, and maresins, have been reported to have several 
pro-resolving functions in the late stages of inflammation36 and possibly also during focal cerebral ischaemia37. 
However, their endogenous time-course of formation in pMCAO is not very clear.
We have used Desorption Electrospray Ionization (DESI) and Matrix Assisted Laser Desorption Ionization 
(MALDI) imaging in time and space to analyse the involvement of selected lipids in the progression and resolu-
tion of the ischaemic insult caused by pMCAO in mice
A list of abbreviations is provided in the supplementary information.
Results
With DESI imaging of selected phospholipid species, we investigated at different post-surgical survival times the 
progression of ischaemia. We used permanent MCAO for induction of ischemia, and our results may thus not be 
applicable for ischemia with transient MCAO, which is a model for the minority of stroke patients having rapid 
reperfusion treatment at a hospital. For all time points investigated by DESI imaging, we used a spatial resolution 
of 100 × 100 μ m2 and measured on sections with 2 h, 24 h, 5d and 20d post-surgical survival. In some of the DESI 
images, a thin line of increased signal intensity is observed along the edge of the tissue. This “edge effect” is occa-
sionally observed in DESI imaging and may be ascribed to differences in surface charging between the tissue and 
the bare glass slide rather than actual higher abundances at the edge of the tissue.
Cessation of the Na+/K+-ATPase activity and activation of phospholipases. In positive ion 
mode, we mainly observed ionized phosphatidylcholine (PC) and to a lesser extent sphingomyelin (SM). PC 
is found both in the outer leaflet of the plasma membrane and the inner membranes (both leaflets) of the cell, 
while SM primarily is found in the outer leaflet of the plasma membrane. Thus, those PC species that predom-
inantly are in the intracellular membranes mainly experience a high potassium concentration, while SM that 
predominantly is in the outer leaflet of the plasma membrane is in contact with a high extracellular sodium 
concentration. In the ischaemic area, lack of oxygen causes fall in the intracellular ATP concentration, influx of 
sodium and calcium over the plasma membrane, followed by activation of one or more of the different subtypes 
of phospholipase A2 and sphingomyelinase, which generates lysophosphatidylcholines (LysoPC) and ceramides 
(Cer) from PC and SM respectively. In Fig. 1, the distribution of the most abundant PC and SM species in the 
brain, PC(16:0/18:1) and SM(d18:1/18:0), are shown using DESI imaging (for molecular structure and MS/MS 
spectra for the two lipids, see Supplementary Fig. S1). The sodium adduct of PC(16:0/18:1) accumulated in the 
ischaemic area at 2 h, 24 h and 5d while it was not observable at 20d in the small remaining injured area. On the 
other hand the potassium adduct disappeared within the same time frame. This can be explained by the ces-
sation of the Na+/K+-ATPase activity, as previously reported13,14. When the pump breaks down sodium floats 
into the cell causing accumulation of the sodium adduct. Furthermore, the activated phospholipase A2 hydro-
lyses PC(16:0/18:1) into LysoPC(16:0), which accumulates here as the sodium adduct. Contrary to this, both the 
sodium and potassium adducts of SM(d18:1/18:0) disappeared from the ischaemic area. This may be due to an 
activated sphingomyelinase, which removes the phosphocholine head group from SM(d18:1/18:0) and gener-
ates Cer(d18:1/18:0), here seen as the sodium adduct. This accumulation of Cer(d18:1/18:0) can be observed at 
24 h and 5d. The potassium adducts of LysoPC(16:0) and Cer(d18:1/18:0) showed the same trend as the sodium 
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Figure 1. Cessation of Na+/K+-ATPase activity and activation of lipases. Mouse brains with 2 h, 24 h, 5d 
and 20d post-surgical survival after the pMCAO-procedure were analysed. The ion images have individual 
intensity bars between 0–100%, and therefore, the intensity colours cannot be compared between two 
images. For each lipid, the ratio between the intensity of the ischaemic area and the comparable size area 
in the contralateral site are shown on the right side where bars are mean ± SEM (n = 3), *p < 0.05. The red 
line indicates ratio = one. The sodium adduct of PC(16:0/18:1) accumulated in the ischaemic area while the 
potassium adduct disappeared. This was caused by the cessation of the Na+/K+-ATPase activity, which indicated 
that this PC species mainly was found intracellularly. In addition to that, LysoPC(16:0) accumulated because of 
the activation of one or more different subtypes of phospholipase A2. Both the sodium and potassium adducts 
of SM(d18:1/18:0) disappeared from the area probably caused by sphingomyelinase degrading SM to Cer. 
Cer(d18:1/18:0) accumulated in the ischaemic area at 24 h and 5d. Since the sodium adduct of SM(d18:1/18:0), 
unlike the sodium adduct of PC(16:0/18:1), did not increase, we concluded that it was mainly found in the outer 
leaflet of the plasma membrane. All images were measured in positive ion mode by DESI imaging with a spatial 
resolution of 100 × 100 μ m2 and the images are a typical representative of 3 mice. Molecular structures of the 
lipids can be found in Supplementary Figures S1 and S3.
www.nature.com/scientificreports/
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adducts, see supplementary Fig. S2 (for molecular structures for LysoPC(16:0) and Cer(d18:1/18:0) and MS/MS 
spectra for LysoPC(16:0), see supplementary Fig. S3). The changes in abundance of the sodium and potassium 
adducts of PC(16:0/18:1) and SM(d18:1/18:0) may also give information about the localizations of these lipids. 
PC(16:0/18:1) was affected by the cessation of the Na+/K+-ATPase activity, suggesting that it mainly is localized 
in the inner leaflet of the plasma membrane as well as the inner membranes of the cell. On the other hand, the 
sodium adduct of SM(d18:1/18:0) was not accumulated, in accordance with its main localization in the outer leaf-
let of the plasma membrane and perhaps also caused by breakdown by sphingomyelinase. To make sure that the 
accumulation of the sodium adduct and the disappearance of the potassium adduct of PC was not caused by ion 
suppression, we sprayed a 24 h section with PC(10:0/10:0) (not present naturally in the brain) before measuring 
by DESI imaging. In supplementary Fig. S4 we tested the effect of ion suppression in the ischaemic area compared 
to healthy brain tissue and concluded that even though the ion suppression of the lipids in the ischaemic area 
seemed less than in the healthy part, this smaller ion suppression may not explain the observed accumulation of 
e.g. LysoPC(16:0) and Cer(d18:1/18:0).
Arachidonic- and docosahexaenoic-rich PCs. Supplementary Fig. S5 shows DESI imaging of the behav-
iour of the sodium and potassium adducts of the PCs containing arachidonic (AA, 20:4(n-6)) or docosahexaenoic 
acid (DHA, 22:6(n-3)). As with PC(16:0/18:1), PC(18:0/22:6) is affected by the cessation of the Na+/K+-ATPase 
activity. We observed accumulation of the sodium adduct and disappearance of the potassium adduct in the 
ischaemic area. Accumulation of the sodium and potassium adduct of LysoPC(18:0) could also be seen hav-
ing the same pattern as the sodium and potassium adduct of LysoPC(16:0), as shown in Supplementary Fig. S7. 
Accumulation of PC(18:0/20:4) followed the same pattern although with a weaker accumulation of the sodium 
adduct. However, we did not observe accumulation of the potassium adduct at 24 h and 5d as reported by Hanada 
et al.12 in ischaemic spinal cord.
Figure 2. Accumulation of monoacylglycerols. (a) MAG(20:4) and MAG(22:6) were measured at 2 h, 24 h, 
5d, and 20d. The ion images have individual intensity bars between 0–100%, and therefore, the intensity colours 
cannot be compared between two images. For each lipid, the ratio between the intensity of the ischaemic area 
and the comparable size area in the contralateral site are shown on the right side where bars are mean ± SEM 
(n = 3), *p < 0.05. The red line indicates ratio = one. At 2 h, no accumulation of the lipids could be seen, at 24 h 
a weak accumulation was seen, and at 5d and 20d a clearer accumulation could be seen in the ischaemic area. 
All images were measured in positive ion mode using DESI imaging with a spatial resolution of 100  ×  100 μ 
m2 and the images are a typical representative of 3 mice. (b) Molecular structure MAG(20:4) (here shown as 
the 2-arachidonoylglycerol sodium adduct ion). (c) Molecular structure of MAG(22:6) (here shown as the 
2-docosahexaenoylglycerol sodium adduct ion).
www.nature.com/scientificreports/
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Figure 3. Accumulation of BMP and NAPE over time during ischaemia. (a) The distribution of NAPE(56:6), 
pNAPE(56:6), and BMP(22:6/22:6) were investigated. The ion images have individual intensity bars between 
0–100%, and therefore, the intensity colours cannot be compared between two images. For each lipid, the ratio 
between the intensity of the ischaemic area and the comparable size area in the contralateral site are shown on 
the right side where bars are mean ± SEM (n = 3), *p < 0.05. The red line indicates ratio = one. The NAPE and 
pNAPE species accumulated both evenly over the ischaemic area at 24 h. At 5 days, NAPE and pNAPE also 
accumulated, however, the abundance of the two lipids were not evenly distributed throughout the area. At 20d, 
NAPE and pNAPE were not detected. BMP was not accumulating until 5d where it seemed to be most abundant 
at the edge, but was in turn still present in the ischaemic area at 20d, where it was evenly spread throughout the 
ischaemic area. All images were measured in negative ion mode using DESI imaging with a spatial resolution 
of 100 × 100 μ m2 and the images are a typical representative of 3 mice. Molecular structure of (b) NAPE(56:6) 
(here shown as NAPE(18:0/22:6/16:0)), (c) pNAPE(56:6) (here shown as pNAPE(18:0/22:6/16:0), and (d) 
BMP(22:6/22:6).
www.nature.com/scientificreports/
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Figure 4. BMP as a biomarker for phagocytosis. MALDI imaging showed the presence of more species of 
BMP. (a) BMP(40:7), BMP(42:10), and BMP(22:6/22:6) all accumulated in the edge of the ischaemic area at day 
5 The ion images have individual intensity bars between 0–100%, and therefore, the intensity colours cannot 
be compared between two images. BMP(22:6/22:6) seemed though to be the most abundant of the three BMP 
species. The images were measured with a spatial resolution of 35 × 35 μ m2. (b) Looking at BMP(22:6/22:6) with 
a higher spatial resolution clearly showed that it accumulated at the edge of the ischaemic area. Abundance of 
www.nature.com/scientificreports/
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Accumulation of monoacylglycerols (MAGs) at the resolution stages of ischaemia. Figure 2a 
shows the tentatively identified distribution of the endocannabinoid MAG(20:4) at the four time points along 
with MAG(22:6), the suggested molecular structures can be seen in Fig. 2b,c, respectively. At 2 h no accumulation 
of the two MAGs was observed, and at 24 h a weak accumulation could be seen. At 5d and 20d, accumulation was 
observed in and especially around the edges of the injured area, where tissue repair is taking place.
Accumulation of N-acyl-phosphatidylethanolamine (NAPE) and bis(monoacylglycero)phos-
phate (BMP) species seen by DESI imaging. In positive ion mode, the observed lipids were mainly seen 
as sodium and potassium adducts, but in negative ion mode they were mainly observed as the deprotonated ion. 
Figure 3a shows the accumulation of NAPE species and BMP(22:6/22:6) during the progression of ischaemia. 
NAPE(56:6) and pNAPE(56:6) accumulated in the ischaemic area at 24 h and 5d, but no accumulation were 
observed at 2 h. At 20d, NAPE and pNAPE had again disappeared. There was no BMP(22:6/22:6) present at 2 h 
and 24 h, but at 5d accumulation of BMP(22:6/22:6) could be seen, especially in the edge of the ischaemic area. At 
20d, BMP(22:6/22:6) was spread out to accumulate in the entire region of the remaining injured area. Comparing 
BMP(22:6/22:6) to NAPE, we saw that the NAPE species were localized all over the ischaemic area at 24 h with no 
BMP(22:6/22:6) present. At 5d, BMP(22:6/22:6) had begun to accumulate and the NAPE species were no longer 
present evenly over the ischaemic area, but had lesser abundance in the regions where BMP(22:6/22:6) were 
located. Going to 20d, the NAPE species had disappeared while BMP(22:6/22:6) had spread to the total remaining 
injured area. Molecular structures of NAPE(56:6), pNAPE(56:6), and BMP(22:6/22:6) are shown in Fig. 3b–d and 
MS/MS spectra and DESI imaging of MS/MS fragments can be seen in Supplementary Figs S8, S9 and S10 for 
NAPE(56:6), pNAPE(56:6), and BMP(22:6/22:6) respectively.
Accumulation of cholesteryl esters (CE) in the resolution phases of inflammation. Cholesteryl 
esters (CEs) were seen to accumulate in the ischaemic area during the resolution phases of inflammation (at day 
5 and 20). Supplementary Fig. S11a shows the distribution of CE(18:1), CE(20:4), and CE(22:6) (the molecular 
structures can be seen in Supplementary Fig. S11b, c and d, respectively). At 2 h, no accumulation of CE could 
be observed, however, at 24 h a weak accumulation of CE(18:1) and CE(20:4) in the ischaemic area were seen. At 
5d and 20d a strong accumulation of all three CE species were observed. The localization of CE seemed to follow 
that of BMP (Fig. 3).
With our MALDI imaging setup, we were able to investigate brain sections with higher spatial resolution 
(smaller pixel size) and thus were able to investigate the sections in greater spatial detail. We measured on sections 
with 5d, 7d and 20d post-surgical survival using MALDI imaging.
Accumulation of NAPE and BMP in the ischaemic area. With DESI imaging, we were only able to 
find one BMP species, BMP(22:6/22:6). However, measuring the samples using MALDI imaging showed us the 
presence of other BMP species in the ischaemic area. Figure 4a shows that, along with BMP(22:6/22:6), we were 
able to find species tentatively identified as BMP(40:7) and BMP(42:10) in brains with 5d post-surgical survival 
(see their molecular structure in Supplementary Fig. S12a and b). Comparing the localization of BMP(22:6/22:6) 
with NAPE(56:6) (Fig. 4), we could see that the two lipids were mainly localized in two different regions of the 
ischaemic area suggesting that where macrophages/microglia cells (i.e. BMP as a biomarker for phagocytosis) 
had phagocytized the dead neurones, NAPE was no longer present (i.e. NAPE as a biomarker for dead/dying 
neurones). NAPE was still present in the area where BMP had not yet accumulated.
BMP as a lipid biomarker for macrophages/microglia cells. LysoPS has been identified as a 
pro-resolving signalling lipid implicated in macrophage activation and clearance of the apoptotic cells27. 
Figure 4b shows the distribution of BMP(22:6/22:6) and LysoPS(18:0) in the ischaemic area in a sample with 
5d post-surgical survival. While LysoPS(18:0) is distributed faintly throughout the section, accumulation of 
LysoPS could also clearly be observed in the edges of the ischaemic area, coinciding with the distribution of 
BMP(22:6/22:6) (See the molecular structure of LysoPS(18:0) in Supplementary Fig. S12c).
To compare the localization of macrophages/microglia cells with BMP, we performed immunohistochemistry 
on the sections by staining for CD11b, a biomarker for macrophages/microglia cells38. In Fig. 4c, we visualized a 
brain section of 5d post-surgical survival using MALDI imaging, followed by immunohistochemical staining of 
the section for CD11b. The distribution of CD11b and BMP(22:6/22:6) coincide, supporting our claim that BMP 
can be used as a biomarker for phagocytizing macrophages/microglia cells. Higher spatial resolutions pictures of 
CD11b clearly showing the staining of individual microglia/macrophages are shown in Supplementary Fig. S13. 
Furthermore, in Fig. 4d we compared the spatial distribution of BMP(22:6/22:6) with the potassium adduct of 
LysoPS(18:0) was seen faintly distributed throughout the section as well as a clear accumulation at the edges 
of the ischaemic area coinciding with BMP(22:6/22:6). The images were measured with a spatial resolution of 
7 × 7 μ m2. (c) After measuring the distribution of BMP(22:6/22:6), the tissue was stained for CD11b to compare 
with the distribution of macrophages/microglia cells. Co-localization of BMP(22:6/22:6) and CD11b is shown 
by overlay. The image was measured with a spatial resolution of 15 × 15 μ m2. (d) The section was first measured 
in negative ion mode to visualize the distribution of BMP(22:6/22:6) and then measured in positive ion mode 
to visualize the distribution of the potassium adduct of CE(18:1). The images were measured with a spatial 
resolution of 35 × 35 μ m2. All images were measured by MALDI imaging on sections with 5 day post-surgical 
survival and the images are a typical representative of 3 mice, except 4d, which is a typical representative of 2 
mice. Molecular structures of BMP(40:7), BMP(42:10, and LysoPS(18:0) are shown in Supplementary Fig. S12.
www.nature.com/scientificreports/
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CE(18:1) on a mouse brain with 5d post-surgical survival by measuring the tissue in both negative and positive 
ion mode. Here we found that BMP and CE co-localized.
Since BMP is especially abundant in alveolar macrophages24, we analysed BMP in TiO2-nanoparticle-exposed 
mouse lungs and in normal control lungs. These MSI images clearly show that BMP(22:6/22:6), and 
LysoPS(18:0) were increased in the TiO2- nanoparticle-exposed lungs compared to the control lungs 
(see Supplementary Fig. S14).
Sphingosine-1-phosphates accumulate in the resolution phase of inflammation. Sphingosine-
1-phosphate has emerged as an important mediator in inflammation regulating immune cell trafficking39. 
Figure 5a shows the accumulation of sphingosine-1-phosphate and CerP(d18:1/16:0) along with the disappear-
ance of C24:1 sulfatide in the ischaemic area in a mouse brain with 7d post-surgical survival. The molecular 
structures of S1P, CerP(d18:1/16:0), and C24:1 Sulfatide are shown in Fig. 5b to d.
Localization of N-acyl-taurines (NAT) in the resolution phases of inflammation. Unexpectedly, 
we found that several species of N-acyl-taurine (NAT) were accumulating in the ischaemic area in the resolution 
phase, while they were not visible at the earlier time points. Figure 6a,b shows the distribution of NAT(18:0) and 
NAT(18:1) at 7d and 20d, respectively. Their molecular structures are shown in Fig. 6c,d.
Fatty acids and their derivates in the resolution phases of inflammation. The importance of 
oxygenated derivatives of liberated fatty acids in the resolution of ischaemia has been realized in recent years. 
Figure 5. Accumulation of Sphingosine-1-phosphate and CerP species. (a) S1P and CerP(d18:1/16:0) were 
found to accumulate in the ischaemic area at 7d post-surgical survival. In contrast, C24:1 Sulfatide disappeared 
from the area. All images were measured in negative ion mode using MALDI imaging with a resolution 
of 15 × 15 μ m2 and the images are a typical representative of 3 mice. Molecular structures of (b) S1P, (c) 
CerP(d18:1/16:0), and (d) C24:1 Sulfatide.
www.nature.com/scientificreports/
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Important fatty acid precursors include DPA (22:5(n-3)) and DHA (22:6(n-3))36. In Fig. 7a, we show the accu-
mulation of DHA, hydroxy-DHA, dihydroxy-DHA, DPA, and dihydroxy-DPA in the ischaemic area after 7d 
post-surgical survival. While these derivates were observed at 7 days, we were not able to find them in any of 
our sections with other survival times (2 h, 24 h, 5d and 20d). Due to their low abundance, we could not perform 
stereo-chemical identification revealing whether they were resolvins, maresins, protectins or other derivatives. 
The molecular structures of DHA and DPA are shown in Fig. 7b,c.
Discussion
The application of MSI for the study of spatiotemporal changes of the inflammatory lipidome during focal cere-
bral ischaemia has brought a number of significant biological results11,13. Initially, we have studied the lipidome 
using the DESI imaging setup, while we later also has access to the MALDI imaging setup, which provide an accu-
rate mass facilitating molecular identification. First, we provide evidence that BMP can be used as a biomarker 
for phagocytizing macrophages/microglia cells in the late resolving state of inflammation as BMP co-localized 
with the macrophage/microglia cells biomarker CD11b. Furthermore, our supplementary studies of abundance 
of BMP in alveolar macrophages support this conclusion. Several different species of BMP could be visualized 
with BMP(22:6/22:6) being the most abundant in the brain, while BMP(36:2) was the most abundant in the lung. 
Furthermore, in the same brain section high abundance of LysoPS(18:0) was also observed. LysoPS is a bioac-
tive lipid mediator, which via activation of G-protein-coupled receptors seems to be involved in stimulation of 
phagocytosis by macrophages during resolution of inflammation27. It was only at day 5 we were able to observe 
LysoPS in the infarcted area, and not at an earlier time-point. In contrast, LysoPC(16:0) was very abundant at 2 h 
and 24 h, although it was still present at 5d and 20d. This seems to be in agreement with the generation of LysoPC 
from injured astrocytes and neurones and that LysoPC may then stimulate the activation of microglia cells40. 
We were not able to find lipid biomarkers, which specifically could visualize the existence of a penumbra within 
the first 2 hours. NAPE species slowly accumulate during cell death41–43 especially in neurones as opposed to 
Figure 6. N-acyl-taurines accumulate in the resolution phase of inflammation. NAT(18:0) and NAT(18:1) 
were both found to accumulate in the ischaemic area at (a) 7 days and (b) 20 days. The images were measured 
at 7d and 20d in negative ion mode using MALDI imaging with a resolution of 25 × 25 μ m2 and 15 × 15 μ m2 
respectively. The images are a typical representative of 3 mice. Molecular structures of (c) NAT(18:0) and (d) 
NAT(18:1).
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astrocytes22,41,43, and we argue that the increased abundance of NAPE in the ischaemic area is caused primarily by 
death of the neurones, which eventually disappear due to phagocytosis by invading macrophages/microglia cells. 
Cholesteryl esters accumulated in the late resolving phase, as also seen by Roux et al. 44. We found that CE(18:1) to 
some extent co-localized with BMP(22:6/22:6) suggesting that cholesteryl esters accumulate in the macrophages/
microglia cells due to phagocytosis of cholesterol-containing dead cells/cell debris. Using higher spatial resolution 
with MALDI imaging, we could see that NAPE did not co-localize with BMP(22:6/22:6) suggesting that where 
NAPE is localized, dead neurones are still present, and where BMP is located dead neurones have been degraded 
by phagocytosis by macrophages. As previously reported13,14, a clear change in the ratio of the potassium and 
sodium adducts of several PC species (e.g. PC(16:0/18:1) and PC(18:0/22:6)) was seen as an indication of their 
intracellular localization and a cessation of the Na+/K+-ATPase activity due to lack of ATP. However, the sodium 
adduct of PC(18:0/20:4) did not clearly increase while the potassium adduct did decrease. Whether this is due to 
this lipid serving as a precursor for generation of LysoPC and arachidonic acid (AA, 20:4(n-6)) metabolites is not 
clear. M. Hanada et al.12 observed that AA-rich PC was temporally elevated one week after spinal cord injury and 
interpreted this as caused by invasive immune cells. We did not observe such a temporally increase in AA-rich 
PC species. The abundance in the ischaemic area of sodium and potassium adducts of SM(d18:1/18:0) decreased 
both in the early phase and the late phase. This may be due to the localization of sphingomyelin mainly in the 
extracellular leaflet of the plasma membrane as well as to the concomitant generation of ceramide (seen both as 
sodium and potassium adducts of Cer(d18:1/18:0)) from sphingomyelin. This generation of ceramide during cell 
death of ischaemia is well-established45 also in MSI studies14,15,46. However, we also observed an increased abun-
dance of both ceramide-1-phosphate (CerP(d18:1/16:0)) and sphingosine-1-phosphate (S1P) in the ischaemic 
area at day 7, with CerP(18:1/16:0) having high abundance in the whole ischaemic area whereas S1P was faintly 
seen in the periphery of the ischaemic area. Both of these lipids have signalling functions28,47 and their formation 
in the later phase of inflammation may suggest that they have some important functions related to the resolution 
of inflammation. S1P has been found to have an inhibitory function on vascular inflammation48.
The endocannabinoid 2-arachidonoylglycerol (2-AG) has been implicated as a neuroprotective factor gen-
erated during the early phase of ischaemia35,49,50. In the present study, we especially saw increased abundance 
of MAG(20:4) also in the later resolution phase of ischaemic inflammation (5d and 20d) while at the same 
time MAG(22:6) also increased in abundance. Since, 2-AG is much more abundant in the brain than 1-AG51, 
we assume that our MAG(20:4) is mainly 2-AG and that MAG(22:6) is mainly 2-docosahexaenoylglycerol 
Figure 7. DHA and DPA are precursors for lipid mediators, which play a role in the resolution phase 
of inflammation. (a) DHA and DPA were accumulating in the ischaemic area at 7d post-surgical survival. 
Likewise, hydroxy-derivatives of these fatty acids were found to accumulate: hydroxy-DHA, dihydroxy-DHA, 
and dihydroxy-DPA were all accumulating in the ischaemic area. These images were measured at 7d in negative 
ion mode using MALDI imaging with a resolution of 15 × 15 μ m2 and the images are a typical representative of 
3 mice. Molecular structures of (b) DHA and (c) DPA.
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(2-DHA-G) respectively. It is not clear whether 2-AG served as agonist for cannabinoid receptor-1 and can-
nabinoid receptor-233 or whether it primarily served as a precursor molecule for formation of various eicosa-
noids34,52. Lipoxin A4 generated from arachidonic acid is known as a pro-resolving lipid mediator53, but a number 
of dihydroxy-derivates of both docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) have also var-
ious pro-resolving activities, having names as resolvins, maresins and protectins36. We observed localization of 
dihydroxy-DHA and dihydroxy-DPA as well as their precursors DHA and DPA in the ischaemic area at day 
7, identified by their exact mass, within the ischaemic area. It was not possible to identify the exact chemical 
structures of these di-hydroxy fatty acids and thereby more exactly suggest their possible biological functions. 
Generally, it is well-known that lack of oxygen leads to post-mortem changes in levels of fatty acids and other sig-
nalling lipids54 as well as of several small water-soluble metabolites55,56. In Fig. 7, DHA is seen in both the ischae-
mic area and in the non-ischaemic area. Furthermore, the decapitation procedure can cause artificial alterations 
in metabolic profiles in some metabolic pathways in the apparently healthy contralateral hemisphere, e.g. increase 
of adenosine monophosphate57.
We believe that the reason for seeing some DHA in the non-ischaemic area is due to post-mortem accumu-
lation during sampling of the brains54. However, DHA intensity is clearly higher in the infarct area reflecting a 
specific release of DHA in this area. By studying the lipids in a defined area with tissue infarct, the non-infarct 
tissue can serve as a sort of control for infarct-specific changes in levels of the lipids, i.e. changes not caused by 
post-mortem lack of oxygen. We also found that many species of N-acyl-taurines (NATs) accumulated in the 
injured area in the resolving phase (7d and 20d). Not much is known about biological functions of NATs, but it 
has been reported that they can activate TRP receptor58 and inhibit proliferation of prostate cancer cells59. Our 
finding of high abundance of NATs during resolution of inflammation raises the question whether they have 
anti-inflammatory functions.
In conclusion, our MSI study has shown that (A) BMP can be used as a biomarker of phagocytizing mac-
rophages/microglia cells in histological studies, (B) NAPE may be a marker for dying/dead neurones, C) the 
ratio of Na+/K+-adducts of selected choline-containing phospholipids in dying cells can suggest whether the 
lipids are localized intracellularly or on the outer leaflet of the plasma membrane, and D) a number of both 
pro-inflammatory and pro-resolving lipid mediators change in abundance between the early pro-inflammatory 
and the late pro-resolving phases of neuroinflammation. Furthermore, this lipidome technique may discover new 
lipid species involved in the inflammatory process. With the present MSI lipidome techniques combined with 
immunohistochemistry, it will in the future be possible to dissect in greater detail the spatiotemporal changes of 
cells and of lipid and peptide mediators during an inflammatory process, and suggests more precise biological 
roles for the various cell types and mediator compounds involved.
Methods
Induction of brain ischaemia. Focal cerebral ischaemia was induced in anaesthetized 7- to 8-week-old 
C57BL/6 male mice by permanent middle cerebral artery occlusion (pMCAO) of the distal part of the left middle 
cerebral artery, as previously described38. Mice were obtained from The Jackson Laboratory (Maine, USA) and 
were cared for in accordance with the protocols and guidelines approved by the Danish Animal Inspectorate (J 
number 2013-15-2934-00924). All efforts were made to minimize pain and distress.
Tissue preparation. Mice were decapitated after cervical dislocation at a range of post-surgical survival 
times. Survival times selected for DESI imaging were 2 h, 24 h, 5d, and 20d, and for MALDI imaging 5d, 7d, and 
20d with three mice at each survival time. The brains were quickly removed from the skulls, frozen in gaseous 
CO2, and subsequently cut into 30 μ m thick coronal cryostat sections. Sections were placed on microscope slides 
and stored in sealed boxes at − 80 °C. Before MSI a section was removed from the freezer and placed in a vacuum 
desiccator for approximately 10 min. to remove water and thus prevent enzymatic reactions in the brain tissue 
during the measurement.
Desorption electrospray ionization (DESI) imaging. DESI imaging was performed on a LTQ XL linear 
ion trap mass spectrometer (Thermo Scientific, California, USA) equipped with a custom-built DESI imaging ion 
source, as previously described60. The electrospray was constructed of coaxial fused silica capillaries connected 
in 1/16-inch Swagelok tee (Swagelok Co., USA), an inner capillary (50 μ m ID, 150 μ m OD, SGE, USA) carrying 
the spray solvent, and an outer capillary (250 μ m ID, 350 μ m OD, SGE, USA) carrying the nebulizer gas. The elec-
trospray was directed toward the surface of the sample in order to desorb and ionize compounds on the surface 
followed by analysis in the mass spectrometer.
The solvent spray consisted of methanol and water (95:5) dispensed with a flow of 5 μ l/min and the nitrogen 
nebulizer gas was set to a pressure of 9 bar. Each mass spectrum was measured with an injection time of 100 ms 
and an average of 5 microscans for positive ion mode and an injection time of 200 ms with an average of 3 micros-
cans for negative ion mode. The spray-to-inlet and spray-to-sample distance were optimized to approximately 
4.5 mm and 1.5 mm respectively with a spray angle of approximately 55°. The spray potential was 5 kV for positive 
ion mode and −5 kV for negative ion mode, and the mass-to-charge (m/z) scan range was set between 250 and 
1100 for all measurements.
Placed on a moving stage, the section was moved under the electrospray for 100 μ m during measurement of 
one mass spectrum. The whole section was recorded line-by-line with a distance of 100 μ m between each line giv-
ing a spatial resolution of 100 × 100 μ m2. In both positive and negative ion mode, measurements were performed 
on brain sections from three different mouse brains, n = 3, and a typical representative were used for the images 
in the figures.
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Matrix assisted laser desorption ionization (MALDI) imaging. A solution of 150 μ l 4-nitroaniline 
(10 mg/mL in acetone/water (50:50, v/v)) was sprayed on the sections with a pneumatic sprayer, as described by 
Bouschen, W. et al.61, with a flow of 10 μ l/min and a pressure of 1 to 2 bar nitrogen gas. While being sprayed the 
section was rotated with approximately 300 to 500 rpm.
After matrix application the sample was placed in an atmospheric-pressure scanning-microprobe matrix 
assisted laser desorption/ionization imaging source (AP-SMALDI10, TransMIT GmbH, Giessen, Germany) cou-
pled to a Fourier transform orbital trapping mass spectrometer (QExactive, Thermo Fisher Scientific GmbH, 
Bremen, Germany). For analyte ionization, a nitrogen laser with a wavelength of 337 nm and a frequency of 60 Hz 
with 30 pulses per shot was used. The laser beam spot size was focused on the sections to match the resolution, 
between 7 × 7 and 50 × 50 μ m2, for a given measurement. Sections were measured in negative ion mode with 
different m/z ranges between 250 and 1200 or positive ion mode with m/z range 250 to 1000. The mass resolu-
tion was 70,000 or 140,000 with the automatic gain control turned off and with a fixed injection time of 500 ms 
(microscans = 1) to match the time of one mass spectrum with the time of one 30 laser pulses.
The measurements in negative ion mode were performed on brain sections from three different mouse brains, 
n = 3, and a typical representative were used for the images in the figures. The only exception to this were the 
images shown in Fig. 4e where tissue sections were measured first in negative and then in positive ion mode to 
compare BMP with CE. These were only measured on tissue sections from 2 different mouse brains.
Microscope images/Toluidine Blue stains. Sections measured in Copenhagen, Denmark were after the 
measurement stained with 0.5% Toluidine Blue (Fluka Analytical, Sigma-Aldrich, Missouri, USA) in water for 
approximately 8 min., and then dehydrated in graded series of alcohol (70–99%), cleared in xylene, and finally 
cover-slipped with Eukitt quick-hardening mounting medium (Fluka Analytical, Sigma-Aldrich, Missouri, USA). 
The Toluidine Blue (TB) stains were then captured on a Stemi DV4 Stereoscope (Carl Zeiss AG, Oberkochen, 
Germany) equipped with an LCMOS digital streaming camera (Brunel Microscopes Ltd, Chippenham, UK). An 
Olympus BX-41 (Olympus Europa, Hamburg, Germany) microscope was used to make optical images of sam-
ples measured in Giessen, Germany prior to MALDI imaging. Images composed of more than one image were 
stitched by the Image Composite Editor (Microsoft Corporation, Washington, USA).
Data analysis of DESI and MALDI imaging. The Raw-files were converted to imzML by an 
imzML-converter62 and loaded into the open-source MS imaging software, MSiReader63. Images were gener-
ated for the m/z values of interest with a bin width of ± 0.1 Da for DESI imaging and ± 5 ppm (± 0.002 Da to ± 
0.004 Da) for MALDI imaging. The images shown in the figures are representatives of images from the three 
different mouse brains measured at each survival time for both DESI and MALDI imaging. To give the best pres-
entation of the images, both on screen and on print, the MATLAB (MathWorks, Massachusetts, USA) colormap 
‘Hot’ was chosen. In some of the figures, semi-quantitative data are given for changes in the abundance of the 
lipids. This has been done by dividing the mean intensity in the injured area with the mean intensity in a compa-
rable area on the contralateral site of the brain section. This was, however, not possible in Fig. 4a due to zero inten-
sity on the contralateral tissue. The data are presented as intensity ratio, mean ± SEM, n = 3 animals. Statistical 
analysis was performed using one-way ANOVA or, if the intensity ratios did not have a normal distribution, 
ANOVA on ranks and statistical significance (*p < 0.05) was determined by using the Student-Newman-Keuls 
Method. Note that the ischaemic area did vary greatly at the different survival times with 24 h having the largest 
area and 20d the smallest.
Immunohistochemistry for CD11b. Immunohistochemical staining for CD11b (macrophages/microglia 
cells) was done with a horseradish peroxidase technique as previously described38. The 4-nitroaniline-matrix was 
removed from the sections by flushing ethanol on the section until the matrix was washed of (around 15 s) and it 
was then left to dry before beginning of the staining procedure.
Designing figures. The figures were composed by loading the generated images from MSiReader together 
with the corresponding microscope image or TB stain into Adobe Illustrator (Adobe Systems, California, USA). 
Arial was used as font for all figures. DESI images were cropped to minimize the surrounding border of the tissue 
in Adobe Photoshop (Adobe Systems, California, USA) before being loaded into Adobe Illustrator.
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